Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

2526-026-STA-WBS Provision of Altuvoct (Efanesoctocog alfa) recombinant FVII

Velindre University NHS Trust

This public procurement record has 1 release in its history.

Award

30 Sep 2026 at 09:45

UK5 - Transparency Notice
Summary of the contracting process

Velindre University NHS Trust is procuring Altuvoct (efanesoctocog alfa), a recombinant factor VIII medicine for treating bleeding disorders. The requirement is for pharmaceutical products, with delivery in Cardiff and Vale of Glamorgan. The Trust’s stated purpose is to give Welsh patients access to this NICE-approved medicine while a contract is being negotiated between the supplier and NHS England. The medicine is not available through the Bleeding Disorders Framework managed by NHS England, prompting a separate purchase by the Welsh health service.

The procurement is complete and Swedish Orphan Biovitrum (SOBI) was selected through a direct award. The Trust’s stated rationale is that SOBI is the sole supplier of the required medicine and that purchase is critical for patient treatment. The award is recorded as pending. The contract period runs from 1 October 2026 to 17 August 2028, with a planned signature date of 1 October 2026. The award value is £270,000 excluding VAT (£324,000 including VAT). The procurement covers one lot. Evaluation was based on the stated sole-supplier technical reason; no further scoring criteria are recorded.

This award shows demand from Velindre University NHS Trust for a specific NICE-approved treatment for bleeding disorders, where patient access is the stated priority. A supplier competing for the same requirement in future would need to be able to supply Altuvoct (efanesoctocog alfa) and demonstrate that it can meet the Trust’s medicine-supply needs. The direct award was justified on the basis that the selected supplier was the sole source of the required product, so the opportunity favours a supplier with access to that medicine rather than a general pharmaceutical distributor. The purchase also reflects a need to provide Welsh patients with access outside the NHS England framework route.

How relevant is this notice?

Notice Information

Notice Title

2526-026-STA-WBS Provision of Altuvoct (Efanesoctocog alfa) recombinant FVII

Notice Description

This note formally records that the Transparency Notice was not published at the required stage of the process, due to a procedural oversight. Once identified, the issue was promptly escalated and corrective action was taken to ensure a notice is completed and published in line with the relevant regulatory and governance requirements. Internal processes and controls have since been reviewed to reduce the risk of this happening again. This medicine is a NICE approved product which is not currently available for procurement under the Bleeding Disorders Framework, managed by NHS England. In order for Welsh patients to obtain access to this medicine while a contract is being negotiated between the supplier and NHS England, this contract is being direct awarded to SOBI.

Procurement Information

Sole supplier of the medicines required and purchase is critical for patient treatment.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-077d18
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/092163-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK5 - Transparency Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£270,000 £100K-£500K
Contracts Value
Not specified

Notice Dates

Publication Date
30 Sep 20266 days ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 Oct 2026 - 17 Aug 2028 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Pending
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Velindre University NHS Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
CARDIFF
Postcode
CF15 7QZ
Postcode Area
Cardiff
Country
Wales
Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL51 Central Valleys and Bridgend
Delivery Location
Not specified
Local Authority
Rhondda Cynon Taf
Electoral Ward
Taff's Well
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

Swedish Orphan Biovitrum (SOBI)

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...